Updated Labeling for Menopausal Hormone Therapy
This Viewpoint describes the US Food and Drug Administration’s intended label updates and removal of black box warnings for menopausal hormone therapy based on current evidence.
Authors
- Martin A. Makary (ORCID: https://orcid.org/0000-0001-6091-4929)
- Tracy Beth Høeg (ORCID: https://orcid.org/0000-0002-2341-6573)
- George F. Tidmarsh
- Christine Nguyen (ORCID: https://orcid.org/0000-0002-5750-8134)
Institutions
- United States Food and Drug Administration (US)
Publication Details
- Journal
- JAMA
- Published
- 2025-11-10
- DOI
- https://doi.org/10.1001/jama.2025.22259
- Citations
- 9
- Primary Topic
- Menopause: Health Impacts and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 11.65